ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND INTELLECTUAL DISABILITY: A STUDY OF ASSOCIATION WITH BRAIN-DERIVED NEUROTROPHIC FACTOR GENE POLYMORPHISMS

被引:31
|
作者
Aureli, A. [1 ]
Del Beato, T. [1 ]
Sebastiani, P. [1 ]
Marimpietri, A. [2 ]
Melillo, C. V. [2 ]
Sechi, E. [2 ]
Di Loreto, S. [1 ]
机构
[1] CNR, Inst Organ Transplantat & Immunocytol ITOI, I-67100 Laquila, Italy
[2] Univ Aquila, Childhood & Adolescence Neuropsychiat Clin, I-67100 Laquila, Italy
关键词
ADHD; intellectual disability; BDNF; polymorphism; ACTIVITY-DEPENDENT SECRETION; COMMON VALINE ALLELE; FACTOR BDNF GENE; VAL66MET POLYMORPHISM; HUMAN-MEMORY; DOPAMINE; RELEASE; NEURONS;
D O I
10.1177/039463201002300323
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Symptoms of attention-deficit hyperactivity disorder (ADHD) have been found in several studies of children with intellectual disabilities (ID) but the two diseases are not always associated. Several lines of evidence implicate the involvement of brain-derived neurotrophic factor (BDNF) in ADHD, and it may also be relevant in ID due to its known involvement in the development of the central nervous system (CNS) and in learning/memory functions. We genotyped paediatric patients with ADHD and ID for the Val66Met and 270 C/T polymorphisms in BDNF. Diagnosis of ADHD and ID was confirmed by the clinicians in accordance with DSM-IV criteria. The G/A genotype of the Val66Met SNP was associated with both ADHD and ID, and the G allele was significantly associated with ADHD. The C/C genotype of the C270T SNP was significantly overrepresented in both ADHD and ID groups compared with the controls. Data suggest that both BDNF polymorphisms could play a role in the etiology of ADHD. In addition, we present the first results suggesting that these BDNF SNPs are significantly associated with ID.
引用
收藏
页码:873 / 880
页数:8
相关论文
共 50 条
  • [31] The role of the brain-derived neurotrophic factor genotype and parenting in early life in predicting externalizing and internalizing symptoms in children with attention-deficit hyperactivity disorder
    Park, Subin
    Kim, Bung-Nyun
    Kim, Jae-Won
    Jung, Yeon-Kyung
    Lee, Jin
    Shin, Min-Sup
    Yoo, Hee Jeong
    Cho, Soo-Churl
    BEHAVIORAL AND BRAIN FUNCTIONS, 2014, 10
  • [32] The role of the brain-derived neurotrophic factor genotype and parenting in early life in predicting externalizing and internalizing symptoms in children with attention-deficit hyperactivity disorder
    Subin Park
    Bung-Nyun Kim
    Jae-Won Kim
    Yeon-Kyung Jung
    Jin Lee
    Min-Sup Shin
    Hee Jeong Yoo
    Soo-Churl Cho
    Behavioral and Brain Functions, 10
  • [33] Serum brain derived neurotrophic factor concentrations in attention deficit hyperactivity disorder (ADHD)
    Gennarelli, M.
    Scassellatil, C.
    Bocchio-Chiavetto, L.
    Tiberti, A.
    Pezzani, M.
    Ottolini, A.
    Zanardini, R.
    Effedri, P.
    Conte, S.
    Filippini, E.
    Valenti, V.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 231 - 232
  • [34] Family-based association study between the brain derived neurotrophic factor (bdnf) gene and the attention deficit hyperactivity disorder in a Mexican population
    Sanchez de la Cruz, J. P.
    Lopez Lopez, A.
    Tovilla Zarate, C. A.
    Molina Solis, R.
    Valencia Hernandez, A.
    Gomez Valencia, L.
    Rivera Angles, M. M.
    Lopez Narvaez, M. L.
    Bermudez Ocana, D. Y.
    EUROPEAN PSYCHIATRY, 2017, 41 : S596 - S597
  • [35] Association study of four polymorphisms of Brain-Derived Neurotrophic Factor (BDNF) gene with schizophrenia
    Skibinska, M.
    Kapelski, P.
    Slopien, A.
    Leszczynska-Rodziewicz, A.
    Godlewska, B.
    Wilkosc, M.
    Tomaszewska, M.
    Dmitrzak-Weglarz, M.
    Czerski, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S215 - S215
  • [36] Association of norepinephrine transporter gene polymorphisms in attention-deficit/hyperactivity disorder in Korean population
    Oh, So-Young
    Kim, Yong-Ku
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2017, 73 : 56 - 63
  • [37] Brain-Derived Neurotrophic Factor in Juvenile Bipolar Disorder and Attention-Deficit Hyperactivity Disorder: differentiation using BDNF serum levels, and Val66Met
    Zeni, C. P.
    Tramontina, S.
    Aguiar, B. W.
    Salatino-Oliveira, A.
    Pheula, G. F.
    Hutz, M.
    Kapczinski, F.
    Rohde, L. A.
    BIPOLAR DISORDERS, 2012, 14 : 48 - 48
  • [38] Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine
    Josep Antoni Ramos-Quiroga
    Margarida Corominas-Roso
    Gloria Palomar
    Nuria Gomez-Barros
    Marta Ribases
    Cristina Sanchez-Mora
    Rosa Bosch
    Mariana Nogueira
    Montserrat Corrales
    Sergi Valero
    Miguel Casas
    Psychopharmacology, 2014, 231 : 1389 - 1395
  • [39] Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine
    Antoni Ramos-Quiroga, Josep
    Corominas-Roso, Margarida
    Palomar, Gloria
    Gomez-Barros, Nuria
    Ribases, Marta
    Sanchez-Mora, Cristina
    Bosch, Rosa
    Nogueira, Mariana
    Corrales, Montserrat
    Valero, Sergi
    Casas, Miguel
    PSYCHOPHARMACOLOGY, 2014, 231 (07) : 1389 - 1395
  • [40] Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD)
    Shim, Se-Hoon
    Hwangbo, Young
    Kwon, Young-Joon
    Jeong, Hee-Yeon
    Lee, Bun-Hee
    Lee, Heon-Jeong
    Kim, Yong-Ku
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (08): : 1824 - 1828